Article | adds $100M+ investments and board of directors

November 5, 2021 | Published by

Gregory and Mark-min

On the left Sir Gregory Paul Winter CBE FRS FMedSci, Nobel Prize-winning British molecular biologist and's board member, right Dr Mark Kotter Founder and CEO 

CAMBRIDGE, UK, Friday 5 November 2021 - CEO Dr Mark Kotter was interviewed by END Points on's $103m Series B fundraise and board appointments.

Mark Kotter 
“I’m not going to say this is going to be easy. It’s going to be super hard, but our advantage is that we’re not fighting a biology that is resisting, you know, scale up and consistency.
Mark Kotter

Founder and CEO


Read the full Endpoints News article.